TransMedics Group, Inc. — Director's Dealing 2024

Dec 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-12-09

Reporting Person: Hernandez Gerardo (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-09	Common Stock	A	12463	—	Acquired	12463	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-09	Stock Option (Right to Buy)	$69.84	A	18922	Acquired	2034-12-09	Common Stock (18922)	Direct

Footnotes

F1: Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer.